Personalis, Inc.
PSNL · Nasdaq · SIC 8071: Services-Medical Laboratories
Business Summary
6 Item 1A. Risk Factors 16 Item 1B. Unresolved Staff Comments 56 Item 1C. Cybersecurity 56 Item 2. Properties 57 Item 3. Legal Proceedings 57 Item 4. Mine Safety Disclosures 57 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 58 Item 6. [Reserved] 58 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 59 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 68 Item 8....
Next Earnings
Q2 FY2026 — expected 2026-08-12
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | PSNL | discussed_in_filing Cybersecurity | |
| topic_mention | PSNL | discussed_in_filing Cybersecurity | |
| topic_mention | PSNL | discussed_in_filing Cybersecurity | |
| topic_mention | PSNL | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076615 | EDGAR | 88K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-029221 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0000950170-24-022097 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0000950170-23-004139 | EDGAR | — |
| 2022-02-24 | 2021-12-31 | 0001564590-22-006722 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001564590-21-008848 | EDGAR | — |
| 2020-03-25 | 2019-12-31 | 0001564590-20-012826 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-04 | 2025-09-30 | 0001193125-25-264708 | EDGAR | 67K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-102993 | EDGAR | — |
| 2025-05-06 | 2025-03-31 | 0000950170-25-064512 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122290 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092883 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0000950170-24-055607 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0000950170-23-060255 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039799 | EDGAR | — |
| 2023-05-03 | 2023-03-31 | 0000950170-23-017182 | EDGAR | — |
| 2022-11-02 | 2022-09-30 | 0000950170-22-021272 | EDGAR | — |
| 2022-08-03 | 2022-06-30 | 0001564590-22-027773 | EDGAR | — |
| 2022-05-04 | 2022-03-31 | 0001564590-22-017858 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-17 | 0001193125-26-110852 | EDGAR | 1K words |
| 2026-02-26 | 0001193125-26-076553 | EDGAR | — |
| 2026-01-08 | 0001193125-26-007037 | EDGAR | — |
| 2025-11-28 | 0001193125-25-302644 | EDGAR | — |
| 2025-11-25 | 0001193125-25-294454 | EDGAR | — |
| 2025-11-10 | 0001193125-25-273416 | EDGAR | — |
| 2025-11-04 | 0001193125-25-264690 | EDGAR | — |
| 2025-08-22 | 0000950170-25-110739 | EDGAR | — |
| 2025-08-05 | 0001193125-25-173575 | EDGAR | — |
| 2025-07-09 | 0001193125-25-157096 | EDGAR | — |
120 total filings indexed. 91 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001527753 |
| Ticker | PSNL |
| Exchange | Nasdaq |
| SIC | 8071: Services-Medical Laboratories |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: ba9805dd5e368dd6286c8d35cc27c25d2db0d583206a3c520fb907203a3417fb
parent: 1d096f7349711206b2c2e40a3f957749babd3b3a76206eb6366b18ac32216f75
content hash: 9f6db8212cbb850982d8f44c426adc85c21c1c29f023516a0891c721f1bff603
signed: 2026-04-13T04:47:01.938Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf